{
"count": 5,
"items": [
{
"nctId": "NCT07465965",
"title": "A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults",
"status": "RECRUITING",
"phases": [
"PHASE1"
],
"studyType": "INTERVENTIONAL",
"enrollment": 60,
"conditions": [
"Overweight",
"Obesity"
],
"interventions": [
"Semaglutide Nasal Spray",
"Placebo",
"Semaglutide Injection"
],
"sponsor": "Shanghai World Leader Pharmaceutical Co., Ltd.",
"startDate": "2026-03-02",
"completionDate": "2026-08-30",
"lastUpdate": "2026-03-12",
"countries": [
"United States"
],
"url": "https://clinicaltrials.gov/study/NCT07465965",
"cached": true,
"cacheAgeSeconds": 286
},
{
"nctId": "NCT07401992",
"title": "Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis",
"status": "RECRUITING",
"phases": [
"PHASE4"
],
"studyType": "INTERVENTIONAL",
"enrollment": 62,
"conditions": [
"Psoriasis (PsO)",
"Obesity & Overweight",
"Diabetes Mellitus - Type 2"
],
"interventions": [
"Semaglutide (Rybelsus®)",
"Placebo"
],
"sponsor": "Hospital Universitario Dr. Jose E. Gonzalez",
"startDate": "2026-01-15",
"completionDate": "2027-02-28",
"lastUpdate": "2026-02-11",
"countries": [
"Mexico"
],
"url": "https://clinicaltrials.gov/study/NCT07401992",
"cached": true,
"cacheAgeSeconds": 286
},
{
"nctId": "NCT07293325",
"title": "Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity",
"status": "RECRUITING",
"phases": [
"NA"
],
"studyType": "INTERVENTIONAL",
"enrollment": 66,
"conditions": [
"Adults With Simple Obesity"
],
"interventions": [
"Semaglutide",
"Tirzepatide",
"Metformin"
],
"sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine",
"startDate": "2025-06-02",
"completionDate": "2027-06-02",
"lastUpdate": "2025-12-19",
"countries": [
"China"
],
"url": "https://clinicaltrials.gov/study/NCT07293325",
"cached": true,
"cacheAgeSeconds": 286
},
{
"nctId": "NCT06989203",
"title": "Protein Supplementation Intervention on Body Weight",
"status": "RECRUITING",
"phases": [
"NA"
],
"studyType": "INTERVENTIONAL",
"enrollment": 140,
"conditions": [
"Obesity",
"Weight Loss",
"Protein Supplementation"
],
"interventions": [
"General lifestyle and nutritional education",
"Calorie-restricted balanced diet",
"semaglutide",
"Dietary protein supplementation"
],
"sponsor": "Chinese Academy of Sciences",
"startDate": "2025-06-10",
"completionDate": "2026-12-31",
"lastUpdate": "2026-03-17",
"countries": [
"China"
],
"url": "https://clinicaltrials.gov/study/NCT06989203",
"cached": true,
"cacheAgeSeconds": 286
},
{
"nctId": "NCT06497595",
"title": "Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide",
"status": "RECRUITING",
"phases": [
"NA"
],
"studyType": "INTERVENTIONAL",
"enrollment": 60,
"conditions": [
"Type 2 Diabetes Mellitus in Obese"
],
"interventions": [
"Wegovy (2.4 Mg Dose) + exercise & nutrition",
"Wegovy (2.4 Mg Dose) + usual care"
],
"sponsor": "Sheba Medical Center",
"startDate": "2025-05-11",
"completionDate": "2027-11-30",
"lastUpdate": "2026-07-21",
"countries": [
"Israel"
],
"url": "https://clinicaltrials.gov/study/NCT06497595",
"cached": true,
"cacheAgeSeconds": 286
}
]
}
curl --location --request GET 'https://zylalabs.com/api/15106/clinical+trials+api/40149/clinical+trials+search?condition=obesity&intervention=semaglutide&status=RECRUITING&maxItems=5' --header 'Authorization: Bearer YOUR_API_KEY'
注册后,每个开发者都会被分配一个个人 API 访问密钥,这是一个唯一的字母和数字组合,用于访问我们的 API 端点。要使用 临床试验 API 进行身份验证,只需在 Authorization 标头中包含您的 bearer token。
| 标头 | 描述 |
|---|---|
授权
|
必需
应为 Bearer access_key. 订阅后,请查看上方的"您的 API 访问密钥"。
|
通过关键词、疾病、干预、赞助商或地点搜索临床试验。返回试验ID、标题、状态、阶段、入组、疾病、干预、赞助商、日期和国家作为JSON
通过关键词、疾病、干预、赞助商或地点搜索临床试验 返回试验ID、标题、状态、阶段、入组、疾病、干预、赞助商、日期和国家作为JSON
每个请求最多返回100条结果。通过maxItems参数进行设置
每个请求从公共源收集实时数据 相同的请求可以从缓存中服务最长达6小时
列表参数接受多个用逗号分隔的值,例如:伦敦,巴黎
该端点接受以下查询参数,均为可选项:查询 条件 干预 赞助商 位置 状态 最大项数 查询:自由文本搜索 条件:条件,例如糖尿病 干预:药物或干预,例如塞马格鲁肽 赞助商:赞助商,例如辉瑞 位置:位置,例如德国 状态:总体状态 最大项数:最大结果(1-50)
`count` 表示请求返回的匹配试验数量。`items` 数组包含相应的试验记录。使用 `count` 判断响应为空、部分返回还是包含多个结果。
结果以 JSON 格式返回,包含顶层字段 `count` 和数组 `items`。每个条目代表一项研究,包含 `nctId`、`title`、`status`、`phases`、`enrollment`、`conditions`、`interventions`、`sponsor`、日期、国家和来源 `url` 等字段娱乐主管
`nctId` 唯一标识该研究,而 `title` 描述该研究。`status` 显示其总体状态,`phases` 列出开发阶段,`enrollment` 给出计划招募的参与者人数。疾病状况、干预措施、申办方、日期和国家/地区提供了研究的其他背景信息.
是的 `phases` `conditions` 和 `interventions` 都是数组 因为一项研究可能涵盖多个阶段或涉及多种疾病和干预措施 请将每个数组作为集合处理 而不要假定只有一个值
记录可能包含不同的研究类型,例如 `INTERVENTIONAL`,并可能涵盖从早期开发到后期研究的各个阶段。`studyType` 和 `phases` 字段会在可用时标识这些类别
使用 `nctId` 作为稳定的研究标识符,用于去重、存储或关联。`url` 指向相应的公开研究页面,例如 `https://clinicaltrials.gov/study/NCT07465965`,以获取更多详细信息
检查 `count` 是否为零,以及 `items` 是否为空。通过减少筛选条件、使用替代关键词或相关疾病和干预名称来扩大搜索范围。不要假设空响应意味着数据源不可用
日期如 `startDate`、`completionDate` 和 `lastUpdate` 均以 ISO 格式(`YYYY-MM-DD`)返回,便于统一排序和解析。`enrollment` 是参与者人数的数值;缺失值应视为不可用,而不是零。